Loading...
XASX
PME
Market cap12bUSD
Sep 17, Last price  
169.22AUD
1D
2.37%
1Q
-2.07%
Jan 2017
3,425.42%
IPO
12,251.82%
Name

Pro Medicus Ltd

Chart & performance

D1W1MN
XASX:PME chart
P/E
66.62
P/S
67.56
EPS
2.54
Div yield, %
0.33%
Shrs. gr., 5y
0.01%
Rev. gr., 5y
30.98%
Revenues
262m
+22.91%
12,539,0009,157,0009,940,00019,197,00013,969,00011,313,00011,154,00014,268,00017,490,00027,521,00031,597,00035,921,00050,105,00056,821,00067,884,00093,461,000124,900,000161,429,000212,905,000261,688,000
Net income
265m
+130.30%
7,052,0007,933,0005,683,0003,920,000503,0001,791,0005,131,0001,509,0003,217,0006,368,0009,321,0009,965,00019,125,00023,076,00030,850,00044,442,00060,648,00082,794,000115,217,000265,344,000
CFO
137m
+22.63%
5,805,0008,810,0005,477,0006,839,0006,250,0005,876,0003,813,0004,233,0004,183,00011,254,00014,829,00013,873,00024,658,00031,592,00039,020,00062,225,00064,773,00086,776,000111,332,000136,523,000
Dividend
Sep 07, 20260.37 AUD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Based in Richmond, Australia, and established in 1983, Pro Medicus Limited is a leading developer and provider of cutting-edge healthcare imaging software and support services. The company caters to a diverse range of medical institutions, including hospitals and diagnostic imaging facilities, across Australia, North America, and Europe. Its comprehensive product suite features a proprietary Radiology Information System (RIS), designed for efficient practice management, which comes complete with training, installation, professional services, and ongoing post-sales support (marketed under names like Visage RIS). Additionally, Pro Medicus offers Promedicus.net, an e-health platform, and advanced healthcare imaging software that empowers radiologists and clinicians with robust visualization capabilities for 2D, 3D, and 4D medical images, alongside its Picture Archiving and Communication System (PACS)/digital imaging solutions (e.g., Visage 7). The company also provides integration products and the Visage Ease Pro mobile application, allowing users to remotely interpret diagnostic imaging studies stored on a Visage 7 server.

Key people

Malte Westerhoff
Global Chief Technology Officer, Managing Director - Visage Imaging GmbH, General Manager - Europe · since 2015
Sam Aaron Hupert
Chief Executive Officer, Managing Director, Executive Director · since 2010
Brad Levin
General Manager � North America and Global Head of Marketing, General Manager - Visage Imaging Inc · since 2015
Danny Tauber
General Manager - Australia · since 2011
Anthony Barry Hall
Technology Director, Executive Director
Teresa Gschwind
Global Head of Customer Service
Sean Lambright
Global Head of Sales
Clayton James Hatch
Chief Financial Officer, Company Secretary · since 2012
Peter Terence Kempen
Non-Executive Independent Chairman of the Board · since 2010
Leigh Farrell
Non-Executive Independent Director · since 2017
Non-Executive Independent Director · since 2016
IPO date
Oct 10, 2000
Employees
79
Domiciled in
AU
Incorporated in
AU

Valuation

Title
AUD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑062025‑062024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑06
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT